Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
28 | ABO | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | |
31 | ACACA | acetyl-CoA carboxylase alpha | |
38 | ACAT1 | acetyl-CoA acetyltransferase 1 | |
39 | ACAT2 | acetyl-CoA acetyltransferase 2 | |
43 | ACHE | acetylcholinesterase (Yt blood group) | |
50 | ACO2 | aconitase 2 | |
142 | PARP1 | poly(ADP-ribose) polymerase 1 | |
175 | AGA | aspartylglucosaminidase | |
229 | ALDOB | aldolase, fructose-bisphosphate B | |
240 | ALOX5 | arachidonate 5-lipoxygenase |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
11450 | Adipoq | adiponectin, C1Q and collagen domain containing | |
16002 | Igf2 | insulin-like growth factor 2 | |
20445 | St6galnac1 | ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 | |
21926 | Tnf | tumor necrosis factor |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
564336 | st6galnac1.1 | ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1, tandem duplicate 1 | |
799868 | st6galnac1.2 | ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1, tandem duplicate 2 |
UniProt ID | Protein Name | Source |
---|---|---|
Q9C0K1 | Metal cation symporter ZIP8 | |
Q9H3Q3 | Galactose-3-O-sulfotransferase 2 | |
Q9HAW7 | UDP-glucuronosyltransferase 1A7 | |
Q9HB29 | Interleukin-1 receptor-like 2 | |
Q9NNX6 | CD209 antigen | |
Q9NPH2 | Inositol-3-phosphate synthase 1 | |
Q9NQ88 | Fructose-2,6-bisphosphatase TIGAR | |
Q9NR19 | Acetyl-coenzyme A synthetase, cytoplasmic | |
Q9NR71 | Neutral ceramidase | |
Q9NSC7 | Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024